Related Experiment Video
Updated: Sep 10, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Identification of Inflammation-Related Diagnostic Biomarker and Molecular Subtypes in Ulcerative Colitis Based on
Fei Dai1, Shufang Ye1, Yabi Zhu1
1Department of Gastroenterology, Lishui People's Hospital, No. 188 Liyang Street, Liandu District, Lishui, 323000, Zhejiang, China.
Background:
Ulcerative colitis (UC) is a chronic and recurrent form of inflammatory bowel disease, primarily involving sustained inflammation of the colonic mucosa. The inflammatory process plays a pivotal role in the pathogenesis and progression of the disorder. Therefore, we conducted this research to explore potential biomarkers and classify molecular subtypes with clinical relevance, which enhances diagnostic accuracy and informs personalized therapeutic strategies.
Methods:
Transcriptomic information was retrieved via the Gene Expression Omnibus (GEO) database. After merging the raw data, differential gene expression analysis was carried out, accompanied by a suite of bioinformatics tools. Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. To screen feature genes, we employed both least absolute shrinkage and selection operator (LASSO) regression and random forest (RF), representing distinct approaches within machine learning. The effectiveness of the selected genes in distinguishing disease status was measured using receiver operating characteristic (ROC) curve analysis, and a nomogram was constructed. We employed single-sample gene set enrichment analysis (ssGSEA) to quantify the enrichment of immune-related signatures at the sample level, while gene set enrichment analysis (GSEA) was conducted to explore key signaling pathways. In addition, drug sensitivity analysis was performed to predict potential therapeutic responses. Ultimately, qRT-PCR analysis was performed to validate the expression patterns of the selected marker genes.
Results:
Two feature genes (CCL11 and MMP1) were identified as diagnostic biomarkers, both demonstrating strong diagnostic performance in ROC curve. A comprehensive nomogram was constructed and shown to possess considerable clinical utility. In addition, significant alterations in immune cell infiltration were identified, and key biological pathways were revealed through GSEA.
Conclusion:
This study identified CCL11 and MMP1 as inflammation-related diagnostic biomarkers for UC through integrated machine learning approaches, offering potential directions aiming at personalized diagnosis and therapeutic intervention.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD